Pharma Research Library | Pharma Info Index Research | Innovation | Opportunities |

About author: Ramesh Dhani JNTUA – OTRI, India E-mail: dhanipharmachem@gmail.com HCC (hepatocellular carcinoma) prognosis remains dismal despite many treatment options. Overall, the cure rate among patients who undergo resection is not very high and for those patients who are not eligible for surgery or percutaneous procedures, only chemoembolization appears to improve survival…Sorafenib, the only drug approved by the United States ... Read More »